MYOCARDITIS
- Go To Page 1
Who is Japanese child pop star Hirata Runa? Died at 8 after developing flu-related heart condition
Hirata Runa, a talented eight-year-old pop star from Japan, tragically passed away due to myocarditis exacerbated by influenza after a concert. As a trainee in the idol group DIANNA Project, Runa's promising career, while brief, left a lasting impression on fans. Her family thanked supporters and requested privacy during this difficult time. The outpouring of grief from the community emphasizes how deeply her performances resonated with so many.
FDA memo on pediatric COVID-19 vaccine deaths sparks concern, expert debate
A leaked FDA memo alleging at least 10 pediatric COVID-19 vaccine deaths, citing myocarditis without data, has sparked alarm. This comes as federal guidance on child vaccinations becomes increasingly divided, with differing recommendations from the CDC, major health organizations, and state coalitions, leaving parents confused.
FDA attributes 10 children's deaths to COVID vaccines
The head of the FDA’s vaccine division said in an internal memo that at least 10 children died “after and because of” receiving a COVID vaccine, linking the cases to myocarditis. The memo, obtained by The New York Times, did not include details about the children or the vaccines involved. The note marks a major shift under Health Secretary Robert F. Kennedy Jr., whose team has tightened access to COVID shots and questioned their safety.
COVID-19 infection vs vaccine side effects: Here’s what Lancet report on children below 18 reveals
A major England study reveals children face greater heart and inflammatory risks from COVID-19 infection than vaccination. Analyzing millions of young people, researchers found infection elevates risks for up to a year, while vaccine side effects like myocarditis are rare and short-lived. This data aids policymakers in assessing infection versus vaccination risks for youth.
FDA issues new heart risk warnings for Pfizer, Moderna COVID vaccines - should you be worried?
The FDA has issued warnings regarding potential cardiac risks, specifically myocarditis and pericarditis, associated with the Pfizer and Moderna COVID-19 vaccines. These risks are particularly elevated in young men, prompting the FDA to update vaccine labels with clearer information. While the FDA continues to monitor vaccine safety and supports their use, ongoing studies are assessing long-term heart effects.
Rory McIlroy reveals battle with serious heart condition after Masters win
Rory McIlroy, the 2025 Masters champion, disclosed his battle with myocarditis since age 20. Despite the heart condition, which he manages with monitoring and hydration, McIlroy secured a historic Masters victory on April 13, completing a career Grand Slam after an 11-year wait. He joins an elite group of golfers with this achievement.
Monkeypox linked to acute heart problem in 1st case study
In a first, a 31-year-old male with confirmed monkeypox infection developed acute myocarditis (inflammation of the heart muscle) approximately one week following the onset of monkeypox symptoms, researchers have revealed.
FDA flags heart issues after taking Novavax vaccine
In the company's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis, a type of heart inflammation also associated with mRNA vaccines, detected within 20 days post vaccination.
Moderna COVID-19 shot more likely to cause heart inflammation than Pfizer's, study shows
Moderna's COVID-19 vaccine is up to four times more likely to cause inflammation of the heart muscle, a very rare side effect, than its rival vaccine from Pfizer-BioNTech , according to a Danish study published in the British Medical Journal late on Thursday.
How often do COVID vaccines cause heart problems in kids?
Myocarditis, an inflammation of the heart muscle, has worried advisers to federal agencies in deliberations regarding use of the Pfizer-BioNTech vaccine in younger children and teenagers. So how common is myocarditis, really? And should parents be concerned about vaccinating their children?
Moderna says its COVID-19 vaccine protective, safe in young children
Moderna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
Load More
